Barbara Zimnoch

Barbara Zimnoch

Auto-generated profile, based on publicly available information

Barbara Zimnoch

Medical University of Bialystok, Jana Kilińskiego 1, 15-089 BiaŁystok, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MBMarta Bonarska
Marta Bonarska
DADamian Adasik
Damian Adasik
KHKatarzyna Herjan
Katarzyna Herjan
KCKatarzyna Chmura
Katarzyna Chmura
BZBarbara Zimnoch
Barbara Zimnoch
KKKatarzyna Kowalska
Katarzyna Kowalska
Background. Regional anesthesia is increasingly used due to its advantages over general anesthesia; however, its potential complications require careful evaluation. Aim. This review aimed to synthesize current evidence on the incidence, risk factors, and prevention of neurological injury, hematoma, and infection associated with regional anesthesia. Material and methods. Relevant peer-reviewed literature—including systematic reviews, retrospective cohorts, and randomized trials—was analyzed to provide a comprehensive overview. Results. Neurological complications, though uncommon, may persist in a subset of patients and are linked to factors such as high-pressure intrafascicular injection and inadequate needle guidance. Hematomas remain rare but are more likely in patients on anticoagulants and can result in permanent deficits if diagnosis and decompression are delayed. Infections, particularly with prolonged catheter use, present a serious risk, with higher rates in peripheral nerve blocks and pediatric populations. Conclusions. Preventive strategies include ultrasound guidance, triple safety protocols, careful antithrombotic management, and strict aseptic techniques. Recent evidence supports the efficacy of real-time pressure monitoring and prophylactic antibiotic use in reducing adverse outcomes. This review underscores the importance of patient-specific risk assessment and adherence to evolving safety protocols in minimizing complications from regional anesthesia.

31 December 2025 in Quality in Sport
Verified
Journal Article
Open access
BZBarbara Zimnoch
Barbara Zimnoch
KCKatarzyna Chmura
Katarzyna Chmura
KRKatarzyna Rendaszka
Katarzyna Rendaszka
KKKatarzyna Kowalska
Katarzyna Kowalska
MPMarta Pyziołek
Marta Pyziołek
JNJoanna Monika Najbar
Joanna Monika Najbar
Background:Aesthetic medicine has advanced rapidly, with dermal fillers becoming essential for facial rejuvenation and contouring. Among biostimulatory fillers, calcium hydroxylapatite (CaHA) is widely studied for its volumizing effect, regenerative potential, and long-lasting results. Aim:This paper reviews CaHA in aesthetic medicine, covering its properties, biodegradability, biocompatibility, mechanism of action, clinical applications, injection techniques, and safety. Methods:Clinical studies, histologic analyses, in vitro research, and systematic reviews were examined to assess CaHA’s effects on tissue remodeling, collagen production, and treatment outcomes. Results:CaHA consists of microspheres in a carboxymethylcellulose gel, providing immediate volume and stimulating neocollagenesis. Studies show increased type I and III collagen, fibroblast activity, and extracellular matrix improvements. Clinically, it effectively treats nasolabial folds, marionette lines, midface volume loss, neck and décolleté laxity, hand rejuvenation, and certain scars. Diluted forms are useful in thin skin areas. Adverse reactions are mostly mild and temporary; serious events are rare and usually technique-related. Conclusions:CaHA is a versatile biostimulatory filler offering immediate support and long-term tissue regeneration. It enhances collagen, improves skin quality, and delivers predictable, safe outcomes for facial and extrafacial rejuvenation.

31 December 2025 in Quality in Sport
Verified
Journal Article
Open access
MSMałgorzata Stróżna
Małgorzata Stróżna
KSKatarzyna Magdalena Stróżna
Katarzyna Magdalena Stróżna
KCKatarzyna Chmura
Katarzyna Chmura
BZBarbara Zimnoch
Barbara Zimnoch
KRKatarzyna Rendaszka
Katarzyna Rendaszka
JNJoanna Monika Najbar
Joanna Monika Najbar
Type 2 diabetes mellitus (T2DM) significantly impairs the physical, psychological and social dimensions of life in affected individuals (1). Proper disease control requires effective self-management to reduce the risk of complications and optimize long-term functioning (2). These activities should extend beyond glycemic regulation to include rehabilitation and complication prevention. Patient education is therefore considered a crucial factor enabling individuals to engage in effective self-management (3). Objective: This review aims to summarize evidence on how patient education influences quality of life (QoL) in people with T2DM (4).Methods: A narrative review was conducted by searching PubMed, Scopus, and Google Scholar for literature from 2010 to 2025 (5). Results: Existing research consistently indicates that structured educational interventions — including Diabetes Self-Management Education (DSME), lifestyle coaching and digital tools — contribute to improved glycemic control, greater disease awareness and enhanced mental health outcomes (6, 7). Educational programs support emotional well-being, increase self-efficacy and strengthen social participation among people with T2DM (8, 9).Conclusions: Patient education is essential for improving QoL and clinical outcomes in Type 2 diabetes (T2DM) patients (10). Personalized and culturally adapted education should be integrated into standard care (11).

6 December 2025 in Quality in Sport
Verified
Journal Article
Open access
KCKatarzyna Chmura
Katarzyna Chmura
MBMarta Bonarska
Marta Bonarska
KKKatarzyna Kowalska
Katarzyna Kowalska
PKPaulina Kwaśniewska
Paulina Kwaśniewska
JNJoanna Najbar
Joanna Najbar
BZBarbara Zimnoch
Barbara Zimnoch
Introduction: Chronic skin diseases impose a multidimensional burden that extends far beyond physical symptoms. Epidemiological evidence consistently reveals a disproportionately high prevalence of psychiatric comorbidities in dermatology patients, particularly anxiety and depression. Historically, the psychological distress observed in this population has been attributed primarily to the psychosocial impact of body image dissatisfaction. However, this perspective is increasingly viewed as incomplete. Emerging research suggests that persistent sleep disturbance acts as a physiological pathway linking cutaneous inflammation to mental health decline, yet its specific role as a functional mediator remains underappreciated. Aim of the study: This review aims to evaluate the evidence supporting sleep disturbance as a key mediator linking cutaneous symptoms to mental health disorders. Materials and method: A narrative literature review was conducted in the PubMed database up to the year 2025. Conclusions: Evidence suggests that nocturnal pruritus cause severe sleep fragmentation and alter sleep architecture, particularly reducing rapid eye movement sleep. This sleep deprivation acts as a primary biological stressor, activating the HPA axis and upregulating pro-inflammatory cytokines, which are shared biomarkers for both cutaneous inflammation and major depressive disorder. Furthermore, sleep loss impairs emotional regulation and lowers the threshold for stress coping, creating a cycle where psychological distress exacerbates skin symptoms. Sleep disturbance is not merely a secondary symptom of skin disease but a critical mediator of psychiatric morbidity. Effective management of chronic skin diseases must include the assessment and restoration of sleep quality. Targeting sleep disruption - through itch control or behavioral interventions - may serve as a potent strategy to prevent the development of secondary mental health problems in dermatological patients.

27 December 2025 in Quality in Sport
Verified
Journal Article
Open access
KKKatarzyna Kowalska
Katarzyna Kowalska
KCKatarzyna Chmura
Katarzyna Chmura
BZBarbara Zimnoch
Barbara Zimnoch
KRKatarzyna Rendaszka
Katarzyna Rendaszka
MPMarta Pyziołek
Marta Pyziołek
JNJoanna Monika Najbar
Joanna Monika Najbar
The aim of this paper is to discuss, based on the literature on the subject, the problem of food addiction, binge eating, anorexia nervosa, and to compare these disorders in terms of their biology and neurobiology. The literature review includes the definition of the concepts of food addiction, binge eating, and anorexia nervosa, the epidemiology of these phenomena based on population studies, the diagnostic criteria for these disorders, and the likely neurobiological factors responsible for their development, as well as a list of types of anorexia nervosa and their differentiation in terms of coexistence with food addiction. The paper also includes a brief discussion of the somatic symptoms observed in the course of obesity and anorexia nervosa.

31 December 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JNJoanna Monika Najbar
Joanna Monika Najbar
KCKatarzyna Chmura
Katarzyna Chmura
BZBarbara Zimnocj Zimnoch
Barbara Zimnocj Zimnoch
KRKatarzyna Rendaszka
Katarzyna Rendaszka
KKKatarzyna Kowalska
Katarzyna Kowalska
MSMałgorzata Stróżna
Małgorzata Stróżna
Background. Diabetic foot syndrome is a severe complication of diabetes mellitus, often complicated by infection, impaired wound healing, and chronic pain. Management is particularly challenging in patients with a history of simultaneous pancreas–kidney transplantation (SPK) and reduced renal function. Aim. To present a complex case of diabetic foot syndrome in a patient after SPK transplantation, highlighting the challenges of pain management and wound care in the context of opioid history and impaired kidney function. Case Presentation. A 65-year-old patient was admitted to the diabetic ward due to worsening pain associated with left diabetic foot syndrome. Physical examination revealed swelling, redness, and purulent discharge. The wound was cleaned, limb offloading was applied, and VAC/NPWT (vacuum-assisted closure/negative pressure wound therapy) was initiated, but the patient continued to experience pain, tension, and discomfort around the wound. Laboratory tests demonstrated decreased estimated glomerular filtration rate (eGFR), and increased levels of uric acid, keratin, and leukocytes. The patient had undergone SPK transplantation 1.5 years prior without complications. History of opioid abuse and limited kidney function posed significant restrictions on analgesic therapy. Conclusions. Diabetic foot syndrome in post-SPK patients presents a multifactorial clinical challenge, requiring careful management of infection, renal impairment, and pain. Individualized, interdisciplinary approaches are essential to optimize wound healing while minimizing opioid use and preventing further complications.